Ovarian cancer stem cells: a new target for cancer therapy.
about
Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth.Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Ovarian tumor-initiating cells display a flexible metabolismDoxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer.Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cellsMathematical models of breast and ovarian cancers.The effect of salinomycin on ovarian cancer stem-like cells.Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer.Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain.Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells.Glutathione in metastases: From mechanisms to clinical applications.Do Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? - Studies with the NTera2 Cell Line.(E)-2,4-Bis(p-hydroxyphenyl)-2-butenal enhanced TRAIL-induced apoptosis in ovarian cancer cells through downregulation of NF-κB/STAT3 pathway.Isolation, identification, and characterization of cancer stem cells: A review.VSV based virotherapy in ovarian cancer: the past, the present and …future?Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell.Identification of long non-coding RNA signature for paclitaxel-resistant patients with advanced ovarian cancer.Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer.Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential.All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells.Cancer stem cells: a new approach to tumor development.Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studiesUltrasound microbubbles mediated miR-let-7b delivery into CD133 ovarian cancer stem cells
P2860
Q33588273-49380FA9-A34E-494F-ABD8-16BC60170CC9Q33890763-DC515ED4-597E-4BF2-9DDB-3E7B4B3DAF44Q34476278-75A70C8D-0D7C-4A8B-AD53-20F34ED7C5C5Q34658326-E0FA537A-9ED7-4A2E-B2E9-2F5BF32437E6Q34715771-1ECD79AB-5A54-4EA5-A922-D10D92F88A22Q35109273-7C41F66F-F8C9-4DD3-8ABB-7C782C05A3CDQ35650181-B8DF0C37-A182-4D30-ACC8-C0DF85CDA859Q36916476-6B423D21-D044-43A3-A3A7-38B3FAC7E044Q37014152-1B7DBE45-4991-48BF-9B9C-5DDBF553E385Q37121113-56DD7A91-FEDE-4F52-A93E-C3CA156856B4Q37341866-8B25BC2F-5326-4589-903E-F09C53DE14ABQ37708778-EBCF58D9-9769-4060-8353-A421EBFF8070Q38668351-5475B0E7-A5DE-4063-8DAE-50BF800110F4Q38692702-41BD2A3B-4DF7-4B77-B7FE-8BBEC040E552Q38699976-D06567DB-714E-4531-BC00-8BCD3114BF66Q39037267-D3E227E6-A4C7-4D16-911B-B0B6CCF1B31FQ39055537-3260712D-965C-4AF0-BB72-07CB39E7FC94Q41441101-290E3F6F-58FD-46E6-9F23-B32B2A79D1DAQ41848132-1E2E8338-645B-4953-9A5B-332B4633D1F4Q42085801-39C878D9-1ED8-406F-A3B1-81B274901891Q47122646-180D524B-5903-4D54-AEBB-85E3F0CFF2DFQ49787658-15AFC9F0-404F-4349-A43D-73A4F19BDC0BQ53222927-83C4FBB1-368B-43F8-9A52-0861659FAEC0Q53531401-3F7FF381-999E-4B57-ABB2-CCB02ABD2926Q58790039-A36EF7AD-B665-41C3-AE77-5A4FF71A58CFQ59125981-B20FE9AB-55BB-425A-8211-48AFD4705B53
P2860
Ovarian cancer stem cells: a new target for cancer therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Ovarian cancer stem cells: a new target for cancer therapy.
@en
Ovarian cancer stem cells: a new target for cancer therapy.
@nl
type
label
Ovarian cancer stem cells: a new target for cancer therapy.
@en
Ovarian cancer stem cells: a new target for cancer therapy.
@nl
prefLabel
Ovarian cancer stem cells: a new target for cancer therapy.
@en
Ovarian cancer stem cells: a new target for cancer therapy.
@nl
P2093
P2860
P921
P356
P1476
Ovarian cancer stem cells: a new target for cancer therapy.
@en
P2093
Chunmei Wang
Qinglei Zhan
Saiming Ngai
P2860
P304
P356
10.1155/2013/916819
P407
P5008
P577
2013-01-30T00:00:00Z